Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Abstract

Characterization of the enantiomers of cis-N-[2-(3,4-dichlorophenyl)ethyl]-N-methyl-2-(1- pyrrolidinyl)cyclohexylamine (BD737 and BD738): novel compounds with high affinity, selectivity and biological efficacy at sigma receptors.

W D Bowen, J M Walker, B R de Costa, R Wu, P J Tolentino, D Finn, R B Rothman and K C Rice
Journal of Pharmacology and Experimental Therapeutics July 1992, 262 (1) 32-40;
W D Bowen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J M Walker
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
B R de Costa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R Wu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
P J Tolentino
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
D Finn
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R B Rothman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
K C Rice
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 262 no. 1 32-40
PubMed 
1320690

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0022-3565
Online ISSN 
1521-0103
History 
  • Published online July 1, 1992.


Author Information

  1. W D Bowen,
  2. J M Walker,
  3. B R de Costa,
  4. R Wu,
  5. P J Tolentino,
  6. D Finn,
  7. R B Rothman and
  8. K C Rice
  1. Section of Biochemistry, Brown University, Providence, Rhode Island.

    Statistics from Altmetric.com

    Article usage

    Article usage: November 2000 to May 2022

    AbstractFullPdf
    Nov 2000100
    Mar 2001200
    Apr 2001100
    May 2001200
    Nov 2001100
    Mar 2002100
    May 2002100
    Jan 2003100
    Jul 2003300
    Aug 2003400
    Sep 2003500
    Oct 2003400
    Nov 2003300
    Dec 2003600
    Jan 2004900
    Feb 2004500
    Mar 2004700
    Apr 2004700
    May 2004700
    Jun 2004600
    Jul 2004900
    Aug 20041100
    Sep 2004400
    Oct 2004500
    Nov 2004400
    Dec 2004200
    Jan 2005300
    Feb 2005100
    Mar 2005700
    Apr 2005200
    May 2005200
    Jun 2005500
    Jul 2005400
    Aug 2005100
    Sep 2005100
    Oct 2005100
    Nov 2005500
    Dec 2005200
    Jan 2006300
    Mar 2006200
    Apr 2006100
    May 2006302
    Jun 2006201
    Jul 2006402
    Aug 2006001
    Sep 2006101
    Oct 2006100
    Nov 2006100
    Dec 2006302
    Jan 2007100
    Feb 2007100
    Mar 2007101
    Apr 2007101
    May 2007300
    Jul 2007100
    Aug 2007201
    Sep 2007201
    Oct 2007301
    Nov 2007100
    Dec 2007203
    Jan 2008200
    Mar 2008200
    Apr 2008101
    May 2008103
    Jul 2008201
    Aug 2008101
    Sep 2008101
    Oct 2008200
    Nov 2008401
    Dec 2008401
    Jan 2009100
    Feb 2009101
    Apr 2009200
    May 2009502
    Jun 2009101
    Jul 2009001
    Aug 2009306
    Sep 20091000
    Oct 2009401
    Nov 2009200
    Dec 2009300
    Jan 2010601
    Feb 2010500
    Mar 2010400
    Apr 2010502
    May 2010402
    Jun 2010402
    Jul 2010101
    Aug 2010301
    Sep 2010200
    Oct 2010200
    Nov 2010200
    Dec 2010500
    Jan 2011300
    Feb 2011201
    Mar 2011700
    Apr 2011800
    May 2011500
    Jun 2011501
    Jul 2011602
    Aug 2011301
    Sep 2011600
    Oct 2011304
    Nov 2011503
    Dec 2011301
    Jan 2012700
    Feb 2012401
    Mar 2012600
    Apr 2012300
    May 2012400
    Jun 2012200
    Jul 2012201
    Aug 2012401
    Sep 2012401
    Oct 2012602
    Nov 2012402
    Dec 2012301
    Jan 2013900
    Feb 2013300
    Mar 20131003
    Apr 2013900
    May 2013400
    Jun 2013402
    Jul 20131200
    Aug 2013101
    Sep 2013300
    Oct 2013201
    Nov 2013101
    Dec 2013202
    Jan 2014400
    Feb 2014100
    Mar 2014403
    May 2014200
    Jul 2014600
    Aug 2014100
    Sep 2014100
    Oct 2014402
    Nov 20141001
    Jan 2015200
    Feb 2015200
    Mar 2015700
    May 2015201
    Jun 2015501
    Jul 2015300
    Aug 2015100
    Sep 2015200
    Dec 2015301
    Jan 2016100
    Mar 20161000
    Apr 2016200
    May 2016201
    Jun 2016300
    Jul 2016102
    Aug 2016506
    Sep 20161001
    Nov 2016500
    Dec 2016801
    Jan 2017200
    Feb 20171000
    Mar 2017300
    Apr 2017200
    May 2017200
    Jun 2017400
    Jul 2017100
    Aug 2017200
    Sep 2017100
    Oct 2017301
    Nov 20171100
    Dec 2017600
    Jan 2018400
    Feb 2018401
    Mar 2018200
    Apr 2018700
    May 2018400
    Jun 2018200
    Jul 2018300
    Sep 2018400
    Oct 2018301
    Nov 2018400
    Dec 2018301
    Jan 2019600
    Feb 2019300
    Mar 2019401
    Apr 2019400
    May 2019400
    Jun 2019002
    Jul 2019600
    Sep 2019600
    Oct 2019300
    Nov 2019900
    Dec 2019501
    Jan 2020301
    Feb 2020300
    Mar 2020402
    Apr 2020100
    May 2020201
    Jun 2020100
    Jul 2020200
    Aug 2020100
    Sep 2020200
    Nov 2020300
    Dec 20201000
    Jan 20211401
    Feb 20211100
    Mar 2021600
    Apr 2021401
    May 20211300
    Jun 2021400
    Jul 2021400
    Aug 2021900
    Sep 2021200
    Oct 2021500
    Nov 20212200
    Dec 2021400
    Jan 2022800
    Feb 2022300
    Mar 2022200
    Apr 2022800
    May 2022500

    PreviousNext
    Back to top

    In this issue

    Journal of Pharmacology and Experimental Therapeutics
    Vol. 262, Issue 1
    1 Jul 1992
    • Table of Contents
    • Index by author
    • Back Matter (PDF)
    • Editorial Board (PDF)
    • Front Matter (PDF)
    Download PDF
    Article Alerts
    Sign In to Email Alerts with your Email Address
    Email Article

    Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

    NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

    Enter multiple addresses on separate lines or separate them with commas.
    Characterization of the enantiomers of cis-N-[2-(3,4-dichlorophenyl)ethyl]-N-methyl-2-(1- pyrrolidinyl)cyclohexylamine (BD737 and BD738): novel compounds with high affinity, selectivity and biological efficacy at sigma receptors.
    (Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
    (Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Citation Tools
    Abstract

    Characterization of the enantiomers of cis-N-[2-(3,4-dichlorophenyl)ethyl]-N-methyl-2-(1- pyrrolidinyl)cyclohexylamine (BD737 and BD738): novel compounds with high affinity, selectivity and biological efficacy at sigma receptors.

    W D Bowen, J M Walker, B R de Costa, R Wu, P J Tolentino, D Finn, R B Rothman and K C Rice
    Journal of Pharmacology and Experimental Therapeutics July 1, 1992, 262 (1) 32-40;

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero

    Share
    Abstract

    Characterization of the enantiomers of cis-N-[2-(3,4-dichlorophenyl)ethyl]-N-methyl-2-(1- pyrrolidinyl)cyclohexylamine (BD737 and BD738): novel compounds with high affinity, selectivity and biological efficacy at sigma receptors.

    W D Bowen, J M Walker, B R de Costa, R Wu, P J Tolentino, D Finn, R B Rothman and K C Rice
    Journal of Pharmacology and Experimental Therapeutics July 1, 1992, 262 (1) 32-40;
    del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Jump to section

    • Article
    • Info & Metrics
    • eLetters
    • PDF

    Related Articles

    Cited By...

    Similar Articles

    Advertisement
    • Home
    • Alerts
    Facebook   Twitter   LinkedIn   RSS

    Navigate

    • Current Issue
    • Fast Forward by date
    • Fast Forward by section
    • Latest Articles
    • Archive
    • Search for Articles
    • Feedback
    • ASPET

    More Information

    • About JPET
    • Editorial Board
    • Instructions to Authors
    • Submit a Manuscript
    • Customized Alerts
    • RSS Feeds
    • Subscriptions
    • Permissions
    • Terms & Conditions of Use

    ASPET's Other Journals

    • Drug Metabolism and Disposition
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    ISSN 1521-0103 (Online)

    Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics